Skip to Main Content
Contribute Try STAT+ Today

In a first-of-its-kind move, the Trump administration will allow Tennessee officials to restrict medicines covered by the state Medicaid program, which is currently required to provide coverage for all treatments.

As part of an effort to overhaul spending by the state program, Tennessee will be permitted to maintain a so-called closed formulary, which is the same approach to coverage taken by private health plans. At the same time, the state program will be able to retain Medicaid drug rebates even as state officials negotiate with drug companies for other supplemental rebates.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.